CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, June 17th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.
This is the first update to the original CTS communication distributed on July 6th. As previously co...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...